Expanding treatment horizons: Advancements in key CRC populations
Details
The Integrated Association of Supportive Care in Cancer (IASCC) is pleased to announce the upcoming focused scientific meeting, “Expanding Treatment Horizons: Advancements in Key CRC Populations,” scheduled on 22nd May 2026 at Courtyard by Marriott, Shillong. Organized under the chairmanship of Dr. Vikas Ostwal and supported by Merck, the meeting will bring together leading oncology experts to discuss evolving treatment paradigms in colorectal cancer (CRC).
The program will feature comprehensive discussions on the current Indian CRC landscape, contemporary treatment challenges, molecular profiling and the role of NGS, anti-EGFR sequencing strategies, management of BRAF V600E and MSI-H disease, resectability in metastatic CRC, and toxicity management of targeted therapies and immunotherapy. The meeting will also highlight emerging evidence, ongoing clinical trials, and future directions in CRC and gastric cancer management through an interactive expert panel and evidence-based scientific sessions.
This academic initiative aims to foster meaningful dialogue and practical insights for oncologists managing complex CRC populations in routine clinical practice.